Form D · Other Health Care
ENDOMEDIX, INC
Montclair, NJ · CIK 0001373977
Offering snapshot reported May 15, 2019 · SEC filing
- Reported sold
- $1.19M Offering amount: $2.55M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 9, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2019 | Initial | $1,186,951 | No comparison | 9 | SEC filing |
| Dec 20, 2011 | Initial | $300,000 | No comparison | 5 | SEC filing |
| Aug 16, 2007 | Paper | Not reported | No comparison | Not reported | |
| Aug 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339663
Source: Form D, filed May 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John M. Abrahams | Director |
| Weiliam Chen | Director |
| Richard Olson | Director |
| James R. Pastena | Director |
| Richard Russo | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1 Normal Avenue, Cels Suite 404
Montclair, NJ, 07043
Montclair, NJ, 07043